Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
4.595
-0.175 (-3.67%)
At close: Mar 13, 2026, 4:00 PM EDT
4.790
+0.195 (4.24%)
After-hours: Mar 13, 2026, 6:50 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $393.29 million as of March 13, 2026. Its market cap has increased by 111.09% in one year.
Market Cap
393.29M
Enterprise Value
222.20M
1-Year Change
111.09%
Ranking
Category
Stock Price
$4.60
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $393.29M, an increase of 246.87%. That is a compound annual growth rate of 23.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 498.97M | 53.01% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 533.61M |
| YD Bio | 528.10M |
| Lyell Immunopharma | 526.32M |
| Contineum Therapeutics | 517.48M |
| Verastem | 512.96M |
| Upstream Bio | 509.85M |
| Invivyd | 508.67M |
| Fulcrum Therapeutics | 508.16M |